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The prolonged use of bisphosphonates has been associated with an increased rate of atypical femoral
fracture. A 77-year-old woman with prolonged bisphosphonate use presented to our ofﬁce with groin
pain and end-stage arthritis, She was scheduled for a total hip replacement. Before the surgery and with
minimal trauma, the patient then suffered a displaced atypical femoral fracture. She underwent a total
hip replacement as a treatment for her fracture and her arthritis. Subsequently, the patient presented
with pain in the contralateral thigh with an incomplete atypical femoral fracture. That side was also
treated with a total hip arthroplasty. An uncemented stem with open reduction internal ﬁxation and a
long cemented stemwere used on the complete fracture and incomplete fracture sides, respectively. At a
follow-up of 2 years, the patient had no pain and had excellent function demonstrating the short-term
success of both cemented and uncemented stems in total hip arthroplasty after atypical femoral
fractures.
© 2016 The Authors. Published by Elsevier Inc. on behalf of The American Association of Hip and Knee
Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Since 2005, it has been reported that long-term bisphosphonate
(BP) therapy could be linked to atraumatic low-energy femoral
fractures [1]. On occasion, these fractures present with no pro-
drome. It seems that the prolonged use of BPs may be associated
with severe suppression of bone turnover, resulting in atypical
insufﬁciency fractures in unusual locations. The majority of these
reports have described fractures in the subtrochanteric region of
the femur. Postulated contributory mechanisms include increased
advanced glycated end products, increased bone matrix minerali-
zation, and the accumulation of microfractures in the zones of
maximal tensile loading combined with suppressed remodeling
rates [2e6].closed potential or pertinent
ent, either direct or indirect,
the biomedical ﬁeld which
rest with this work. For full
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Suite 600, South Miami, FL,
Inc. on behalf of The American Asso
c-nd/4.0/).Several case series have discussed the outcomes of the opera-
tive management of atypical femoral fractures (AFFs). Weil et al.
[7] reviewed the clinical data from 15 patients with 17 AFFs
associated with long-term BP use who were treated surgically. The
rate of fracture healing after the initial procedure among patients
treated with intramedullary nails was 54%, with the remainder of
patients requiring reoperation. The authors attributed this high
failure rate to qualitative bone defects caused by long-term BP use.
Prasarn et al. [8] compared the rate of intraoperative fractures and
postoperative plate failures in 25 patients with BP-related femoral
shaft fractures with 20 control patients having similar fracture
types but without a history of BP use. The BP group had a
signiﬁcantly higher rate of major complications, including intra-
operative fracture, implant failure, nonunion, malunion, and per-
iprosthetic fractures. To assess the efﬁcacy of the nonoperative
treatment of BP-related AFFs, Banffy et al. [9] retrospectively
reviewed 34 patients with 40 BP-related AFFs. The authors
concluded that the nonoperative treatment of these BP-related
AFFs is not feasible or reliable because most of these lesions
progress to complete fractures.
We present the case of a patient who sustained a bilateral AFF
subsequent to the prolonged use of BP and was treated with
bilateral total hip arthroplasty (THA) using 2 different methods ofciation of Hip and Knee Surgeons. This is an open access article under the CC BY-NC-
S.M. Sandilands et al. / Arthroplasty Today 2 (2016) 147e152148femoral implant ﬁxation. To our knowledge, this is the ﬁrst case
reported with such treatment modalities.Case history
The patient was informed that the data concerning her case
would be submitted for publication, and the patient agreed.
A 77-year-old Hispanic female initially presented to our ofﬁce
with right groin pain and severe radiographic arthritis of both hips.
The patient was using a cane for ambulation. Her medical history
was signiﬁcant for osteoporosis, for which the patient was taking
alendronate sodium. In addition, the patient had bilateral total knee
arthroplasties performed 15 years before the initial ofﬁce visit. Her
activity level according to the University of California, Los Angeles
(UCLA) activity-level rating scale was a 3 out of 10 (sometimes
participates in mild activities as walking, limited housework, and
limited shopping). The patient’s Harris Hip Score was 41 (range,
0-100). On the pain visual analog scale, her right hip pain was
graded in both intensity and frequency as 9/10. Preoperatively, her
vitamin D level was 33.8 ng/mL and her calcium level was 8.8 mg/
dL. On the physical examination, her right hip range of motion was
the following: ﬂexion: 100, abduction: 35, adduction: 30, in-
ternal rotation: 20, and external rotation: 40. The Trendelenburg
test was positive with a lurch. She had no deﬁcits in motor strength.
The pelvis radiograph showed severe osteoarthritis (OA) of both
hips, with the right hip worse than the left (Fig. 1). The patient was
therefore diagnosed with end-stage OA of both hips. As the right
hipwasworse than the left hip, a right THAwas planned. Before her
surgery, the patient was sent for a bone scan to evaluate a bony
island seen on her preoperative hip radiographs (Fig. 1, black circle).
The bone scan showed focal activity on the lateral aspect of the
proximal right femur, distal to the bone island, and on the midshaft
of the left femur; ﬁndings were consistent with a most likely
diagnosis of an impending AFF based on her medical history and
the prolonged use of BP (Fig. 2). However, owing to the nonspeciﬁc
nature of the bone scan results, the patient was instructed to get a
magnetic resonance imaging (MRI) scan to further evaluate these
areas of increased signal in both femurs.
Before the date of her THA and planned MRI of her right and left
femurs, however, the patient presented to the emergency room
with right hip pain after sustaining a fall from a standing height.
The patient denied any loss of consciousness or vision, chest pain,Figure 1. Preoperative anteroposterior pelvis radiograph showing severe bilateral OA
of the hips, with the right side worse than the left side.or dizziness before or after the fall. Her radiograph of the right hip
(Fig. 3) at the time of the fall showed severe OA of the right hip and
a noncomminuted subtrochanteric femoral fracture with the frac-
ture line beginning at the lateral cortex and continuing medially in
a transverse orientation, an AO 32-A3.1 type fracture. This fracture
pattern is consistent with an AFF, based on criteria by Shane et al.
[1]. Owing to the underlying OA of the right hip, the patient un-
derwent a right THA with open reduction internal ﬁxation of the
fracture (Fig. 4). The femoral stem placed was a 140 mm-by-180
mm 70% porous-coated straight revision stem. Fracture treatment
was completed using the principles of periprosthetic fracture ﬁx-
ation as described by Shah et al. [10]. The subtrochanteric fracture
was further stabilized with 2 ﬁbular strut grafts that were secured
in place with Luque wires at 3 levels.
Postoperatively, the patient was placed on our standard anti-
coagulation protocol for a total of 6 weeks. Her weight-bearing
status was toe-touch weight-bearing on the right lower extremity
for a total of 6 weeks. She continued to progress well post-
operatively in a rehabilitation facility until two and a half weeks
after her right THA. At that point, the patient unexpectedly began to
complain of severe left hip pain with associated thigh pain. The
radiographs (Fig. 5a) and the MRI of her left hip (Fig. 5b and c)
showed a thickening of the lateral cortex with a partial cortical
disruption of this cortex (white asterisks on Fig. 5b and c) which
were interpreted as impending AFFs.
Preoperatively, her activity level (based on the UCLA activity-
level rating scale) was rated as a 3 out of 10 (sometimes partici-
pates in mild activities as walking, limited housework, and limited
shopping). The patient’s Harris Hip Score was 41. On the pain visual
analog scale, her pain was graded 6.5/10 for intensity and 7/10 for
frequency. On the physical examination, her left hip range of mo-
tionwas the following: ﬂexion: 90, abduction: 30, adduction: 25,
internal rotation: 20, and external rotation: 30. The patient had
no deﬁcits in motor strength.
Because of the underlying and known severe OA of the hip as
well as the impending AFF, the patient underwent a cemented left
THA (Fig. 6). To allow for adequate ﬁxation of the impending
midshaft fracture, a 210-mm cemented revision stemwas placed to
function as an intramedullary device, as described in the principles
of impending AFF ﬁxation by Borrelli et al. [11]. Postoperatively, the
patient was restarted on the standard anticoagulation protocol for a
total of 6 weeks. In the immediate postoperative period, she was
bearing full weight on the left lower extremity. The patient
continued to do well postoperatively, and she recovered
uneventfully.
At the 1-year follow-up visit, her UCLA activity level was
graded as a 6 out of 10 (regularly participates in moderate activ-
ities). The patient’s Harris Hip Score was 89. On the pain visual
analog scale, her pain was graded 0/10 for both intensity and
frequency. On the physical examination, her right hip range of
motion was as follows: ﬂexion: 95, abduction: 30, adduction:
25, internal rotation: 20, and external rotation: 45. Her left hip
range of motion was the following: ﬂexion: 90, abduction: 30,
adduction: 20, internal rotation: 10, and external rotation: 60.
She had no deﬁcits in motor strength. The Trendelenburg test was
normal. The 1-year follow-up radiographs showed excellent
positioning of all components with evidence of healing along the
right femur (Fig. 7). Functionally, the patient had minimal difﬁ-
culty ambulating.
At the latest follow-up visit (2 years), she continues doing well.
She has been ambulating without difﬁculty and is able to get
around within the community with minimal difﬁculty. Her hip
range of motion remains excellent, and at this most recent visit,
there are no radiographic signs of loosening or instability in both
hip arthroplasties (Fig. 8a, b, and c).
Figure 2. Whole-body bone scan showing focal activity on the lateral aspect of the proximal right femur and on the midshaft of the left femur.
Figure 3. Anteroposterior radiograph of right hip after fall causing AFF. Figure 4. Postoperative anteroposterior radiograph of right hip.
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Figure 5. (a) Anteroposterior radiograph of left hip showing impending AFF. (b) T1 MRI of left hip showing impending AFF (at asterisk). (c) T2 MRI of left hip showing impending
AFF (at asterisk).
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An AFF is deﬁned as a transverse or short oblique non-
comminuted fracture occurring between the subtrochanteric and
supracondylar regions with no or only minor trauma [1]. The
fracture is thought to be caused by modiﬁcation of collagen cross-
linking, accumulation of bone microdamage, increased minerali-
zation or reduced heterogeneity of mineralization, change in bone
metabolism, or reduced angiogenesis [12]. The mechanism
by which BPs are thought to cause AFF is by inhibitingosteoclast-mediated bone resorption, leading to inhibition of the
normal bone remodeling process at the location of microfractures
that normally occur [1,13]. Typical symptoms before the fracture
are thigh or groin pain [4,14,15]. We classiﬁed both femoral frac-
tures in the present case as AFFs because of the patient’s history
of long-term BP intake and the characteristic morphologic ﬁnd-
ings seen on the radiographs. In addition, the left impending
femoral fracture was noted during the postoperative period while
the patient was in a rehabilitation facility and without any
instance of trauma.
Figure 6. Postoperative anteroposterior radiograph of left hip.
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AFF have been described. Operative treatment of the impending
AFF uses intramedullary nailing or plating techniques, with
excellent outcomes as shown by Egol et al. [16]. For nonoperativeFigure 7. One-year follow-up radiographs: (a) anteropostetreatment, the impending AFF is treated with partial weight-
bearing plus or minus teriparatide treatment; results are mildly
effective and many patients progress to a complete AFF [11]. Our
case of complete and impending AFFs was treated with a long-
stem uncemented THA with strut grafts on the right side and a
long-stem cemented THA on the left side instead of internal ﬁx-
ation because the patient had concomitant symptomatic end-
stage OA of both hips. We think that using the long-stem THA
was a better choice to treat both pathologies simultaneously,
when compared with completing internal ﬁxation of the fractures
and staging the total hips at a later time, because we were able to
limit the number of procedures to 2 surgeries instead of 4 sur-
geries. To the best of our knowledge, there are no reports or
guidelines concerning a speciﬁc course of action on the use of
cemented or uncemented THA in face of atypical fractures. Our
rationale for using an uncemented stem was the following: We
used an uncemented stem with strut grafts on the right side to
give extra support to the fracture site and enhance union without
causing any leakage of cement into the fracture site which would
have been the case if a cemented stem was used. The cemented
stem was used on the left side to give extra support at the level of
the impending AFF but, because it was not a complete
fracture, the leakage of cement into the fracture site was not a
concern.
Evidence-based studies, mostly large case series or retrospec-
tive studies, demonstrate an association between AFFs and BP use.
However, large-scale epidemiologic studies have not conﬁrmed
this association [17]. It is important to note that these AFFs are rare
and occur in a very small number of patients taking this type of
treatment. We do not want to downplay the signiﬁcant role of BPs
in the treatment of osteoporosis [1]. Further research should
include long-term, prospective observational studies examining
the development of AFFs; speciﬁc data on bone biopsies and
fracture healing in BP-treated patients; and further analyses of
clinical, biomechanical, and genetic factors pertinent to the
development of AFFs. Basic science investigations should examine
the signiﬁcance of cortical thickening, an unexplained feature of
atypical fractures that may provide valuable insights into their
pathomechanism.rior pelvis, (b) lateral left hip, and (c) lateral right hip.
Figure 8. Two-year follow-up radiographs: (a) anteroposterior pelvis, (b) lateral left hip, and (c) lateral right hip.
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We present the case of a patient who suffered a bilateral AFF in a
short period of time around arthritic hips. This particular case il-
lustrates that patients under prolonged BP therapy are at risk for
AFFs even in the most controlled situations such as in the imme-
diate postoperative period after a THA. This case also illustrates the
short-term success of both cemented and uncemented total hip
arthroplasties in the presence of these fractures.
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